VOYA Investment Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,242
| Closed | -$284K | – | 2503 |
|
|
2026
Q1 | $284K | Hold |
13,242
| – | – | ﹤0.01% | 1975 |
|
|
2025
Q4 | $123K | Hold |
13,242
| – | – | ﹤0.01% | 2233 |
|
|
2025
Q3 | $93.4K | Sell |
13,242
-6,373
| -32% | -$43.8K | ﹤0.01% | 2312 |
|
|
2025
Q2 | $127K | Buy |
19,615
+5,140
| +36% | +$35.4K | ﹤0.01% | 2430 |
|
|
2025
Q1 | $115K | Sell |
14,475
-1,326
| -8% | -$14.3K | ﹤0.01% | 2409 |
|
|
2024
Q4 | $200K | Sell |
15,801
-1,648
| -9% | -$22.9K | ﹤0.01% | 2396 |
|
|
2024
Q3 | $243K | Sell |
17,449
-18,340
| -51% | -$262K | ﹤0.01% | 2371 |
|
|
2024
Q2 | $493K | Sell |
35,789
-2,409
| -6% | -$35.2K | ﹤0.01% | 2009 |
|
|
2024
Q1 | $631K | Sell |
38,198
-4,673
| -11% | -$69.9K | ﹤0.01% | 1894 |
|
|
2023
Q4 | $626K | Buy |
42,871
+298
| +0.7% | +$3.61K | ﹤0.01% | 1951 |
|
|
2023
Q3 | $522K | Buy |
42,573
+5,786
| +16% | +$75.5K | ﹤0.01% | 2016 |
|
|
2023
Q2 | $439K | Buy |
36,787
+8,889
| +32% | +$116K | ﹤0.01% | 2156 |
|
|
2023
Q1 | $373K | Hold |
27,898
| – | – | ﹤0.01% | 2207 |
|
|
2022
Q4 | $600K | Hold |
27,898
| – | – | ﹤0.01% | 1925 |
|
|
2022
Q3 | $559K | Buy |
+27,898
| New | +$593K | ﹤0.01% | 1959 |
|
Other funds holding DAWN
VOYA Investment Management's DAWN Position: Q2 2026 in Review
VOYA Investment Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 13,242 shares — an estimated $284K sold.
VOYA Investment Management first reported a position in DAWN in Q3 2022 and held it in 15 quarters. The position peaked at $631K in Q1 2024. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- VOYA Investment Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- VOYA Investment Management sold 13,242 Day One Biopharmaceuticals shares in Q2 2026, an estimated $284K.
- VOYA Investment Management first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 15 quarters.
- VOYA Investment Management's Day One Biopharmaceuticals position peaked at $631K in Q1 2024.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.